Core Viewpoint - Fiserv, Inc. is facing a securities fraud class action lawsuit due to misleading statements and omissions regarding its business initiatives during the specified class period [3][4]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased Fiserv securities from July 23, 2025, to October 29, 2025 [3]. - Allegations include that Fiserv made misleading statements about its initiatives and projects [3]. Impact on Stock Price - On October 29, 2025, Fiserv disclosed that its 2025 guidance was based on assumptions that were difficult to achieve, leading to a significant stock price drop of $55.57, or approximately 44%, from $126.17 to $70.60 [4]. Investor Actions - Investors who suffered losses on Fiserv investments have until January 5, 2026, to request lead plaintiff appointment [2]. - The law firm Kirby McInerney LLP is encouraging affected investors to contact them for discussions regarding their rights at no cost [1][4].

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds Firefly Aerospace Inc. ("Firefly†or the "Company†) (NASDAQ:FLY) investors of the January 12, 2026 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Firefly securities between August 4, 2025 through September 29, 2025 ("the Class Period†). 22, 2025 earnings call that the Company "expect[ed] to launch Flight 7 in the coming weeks.†Following on the heels of Firefly's failed April 2 ...

Core Viewpoint - Venu Holding Corporation is under investigation for potential violations of federal securities laws and unlawful business practices by its senior management [1]. Group 1: Company Overview - Venu conducted its initial public offering on November 27, 2024, offering 1.2 million shares at a price of $10.00 per share [3]. - The company reported third-quarter financial results on November 14, 2025, with revenue of $5.38 million, which is a 1.3% decline year-over-year and $2.05 million below consensus estimates [3]. Group 2: Market Reaction - Following the financial results announcement, Venu's share price dropped by $2.37, or approximately 21.45%, from $11.05 on November 14, 2025, to close at $8.68 on November 17, 2025 [3].

Core Viewpoint - Anika Therapeutics, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following the release of disappointing clinical trial results for its product Hyalofast [1][3]. Group 1: Investigation Details - The law firm Kirby McInerney LLP is leading the investigation into Anika Therapeutics [1]. - The investigation focuses on whether Anika and/or its senior management engaged in unlawful practices related to the company's securities [1]. Group 2: Clinical Trial Results - On July 30, 2025, Anika announced topline results from a clinical trial of Hyalofast, which is a resorbable hyaluronic acid scaffold for cartilage repair [3]. - The trial showed consistent improvements in treated patients compared to microfracture, but did not meet its pre-specified co-primary endpoints [3]. - Factors affecting the trial results included a higher dropout rate in the microfracture arm and missed visits during COVID, leading to missing data and a reduced evaluable sample size [3]. - Following the announcement, Anika's share price fell by $3.06, or approximately 27.42%, closing at $8.10 per share [3].

Core Viewpoint - A class action lawsuit has been filed against Fiserv, Inc. for allegedly making misleading statements regarding its initiatives and projects during the class period from July 23, 2025, to October 29, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Fiserv's 2025 guidance, disclosed in July 2025, was based on assumptions that were "objectively difficult to achieve" [2]. - Following the revelation of these assumptions, Fiserv's share price dropped by $55.57, approximately 44%, from $126.17 on October 28, 2025, to $70.60 on October 29, 2025 [2]. Group 2: Lead Plaintiff Process - Investors who acquired Fiserv securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, with courts typically appointing those with the largest financial loss [3]. - Lead plaintiffs have the authority to influence case strategy, settlement decisions, and allocation of settlement funds among class members [3]. Group 3: Contact Information - Investors who purchased or acquired Fiserv securities and wish to learn more about the investigation can contact Kirby McInerney LLP for further information [4].

Core Viewpoint - StubHub Holdings, Inc. is facing a federal securities class action lawsuit related to its September 2025 IPO, with allegations of misleading information regarding its financial performance and cash flow [4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired StubHub securities based on the offering documents from the IPO [4]. - Allegations include failure to disclose changes in vendor payment timing, which adversely affected free cash flow [4]. - The lawsuit claims that the misleading information resulted in materially misleading IPO offering documents [4]. Group 2: Financial Performance - StubHub reported a free cash flow of negative $4.6 million for Q3 2025, a 143% decrease from the previous year's positive free cash flow of $10.6 million [5]. - Following the earnings release, StubHub's share price dropped by $3.95, or approximately 21.0%, from $18.82 to $14.87 [5]. - By November 24, 2025, StubHub's stock price fell to $12.01, nearly 50% below the IPO price of $23.50 [6].

[CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Is The Lawsuit About? The lawsuit has been filed on behalf of investors who purchased securities during the period of January 27, 2025 through October 27, 2025, inclusive ("the Class Period†). The lawsuit alleges that the Company did not have "reliable information pertaining to the Company's leasing spreads, development tenant pipeline, and anticipated occupancy growth for its life-science properties, specifically its Long Island City ("LIC†) property while ...

Core Viewpoint - Klarna Group plc is under investigation for potential violations of federal securities laws and unlawful business practices following disappointing Q3 2025 financial results that led to a significant drop in share price [1][3]. Group 1: Company Overview - Klarna launched its IPO in September 2025, selling 34,311,274 shares at a price of $40.00 per share [3]. - The company reported a substantial increase in the provision for credit losses in its Q3 2025 financial results [3]. Group 2: Financial Impact - Following the announcement of Q3 results, Klarna's share price fell by $3.25, or approximately 9.3%, from $34.88 on November 17, 2025, to close at $31.63 on November 18, 2025 [3].

Core Viewpoint - The lawsuit against DeFi Technologies alleges securities fraud, claiming that the company misled investors regarding its operational challenges and financial performance during the specified class period [3]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased DeFi securities from May 12, 2025, to November 14, 2025, alleging that the company made false statements and failed to disclose critical operational issues [3]. - Key allegations include delays in executing the DeFi arbitrage strategy, underestimating competition from digital asset treasury companies, and the likelihood of not meeting revenue guidance for fiscal year 2025 [3]. Financial Performance - On November 6, 2025, DeFi reported that "DATs have absorbed or delayed a significant share of arbitrage opportunities," leading to a share price decline of approximately 7.43%, from $1.75 to $1.62 [4]. - On November 14, 2025, DeFi announced a nearly 20% revenue decline, significantly lowering its 2025 revenue forecast from $218.6 million to approximately $116.6 million, attributing this to delays in executing arbitrage opportunities [5]. - Following the financial results announcement, DeFi's share price fell by approximately 14.63%, from $1.23 to $1.05 [5].

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Firefly Aerospace Inc. (“Firefly” or the “Company”) (NASDAQ:FLY) investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. If you purchased or otherwise acquired Firefly securities, have information, or would like to learn more, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the form below, to discuss your rights or ...